Molecular Imaging Research, Inc. (MIR) We are a specialty Contract Research Organization (CRO) providing small animal in vivo multi-modality imaging services (anatomical, functional, molecular) across therapeutic areas. We are the only CRO dedicated to providing these services. Our company complements its imaging expertise with deep pharmacology and models expertise to optimize pharmacology imaging projects. Modalities include small animal MRI, PET and CT, bioluminescence, fluorescence, DEXA and 2D X-ray, and will soon expand to incorporate modalities such as FMT, SPECT and ultrasound. The company offers a broad array of subcutaneous, orthotopic and metastasis tumor models as well as all the most common rheumatoid arthritis models. Through nearly a decade of CRO imaging experience, it combines broad protocol and model validation, optimized imaging/data throughput and strong client-oriented project management. Highly focused on imaging services and related pharmacology work, we continue to continue to have the necessary pharmacology and models expertise necessary as a platform for myriad imaging services, and we conduct efficacy/dose tolerance testing contingent for planned imaging studies.